Logo image of CDRE

CADRE HOLDINGS INC (CDRE) Stock Fundamental Analysis

USA - NYSE:CDRE - US12763L1052 - Common Stock

33.77 USD
-0.53 (-1.55%)
Last: 9/19/2025, 8:04:00 PM
33.77 USD
0 (0%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

6

Overall CDRE gets a fundamental rating of 6 out of 10. We evaluated CDRE against 69 industry peers in the Aerospace & Defense industry. While CDRE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CDRE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CDRE had positive earnings in the past year.
In the past year CDRE had a positive cash flow from operations.
In the past 5 years CDRE has always been profitable.
In the past 5 years CDRE always reported a positive cash flow from operatings.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

With a decent Return On Assets value of 4.80%, CDRE is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a decent Return On Equity value of 11.46%, CDRE is doing good in the industry, outperforming 76.81% of the companies in the same industry.
CDRE has a better Return On Invested Capital (7.10%) than 65.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CDRE is in line with the industry average of 8.29%.
Industry RankSector Rank
ROA 4.8%
ROE 11.46%
ROIC 7.1%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

With a decent Profit Margin value of 6.65%, CDRE is doing good in the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CDRE has grown nicely.
With a decent Operating Margin value of 12.22%, CDRE is doing good in the industry, outperforming 78.26% of the companies in the same industry.
CDRE's Operating Margin has improved in the last couple of years.
The Gross Margin of CDRE (41.49%) is better than 84.06% of its industry peers.
In the last couple of years the Gross Margin of CDRE has grown nicely.
Industry RankSector Rank
OM 12.22%
PM (TTM) 6.65%
GM 41.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CDRE is destroying value.
Compared to 1 year ago, CDRE has more shares outstanding
The number of shares outstanding for CDRE has been increased compared to 5 years ago.
Compared to 1 year ago, CDRE has a worse debt to assets ratio.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 3.25 indicates that CDRE is not in any danger for bankruptcy at the moment.
CDRE has a Altman-Z score of 3.25. This is comparable to the rest of the industry: CDRE outperforms 49.28% of its industry peers.
CDRE has a debt to FCF ratio of 9.51. This is a negative value and a sign of low solvency as CDRE would need 9.51 years to pay back of all of its debts.
CDRE has a better Debt to FCF ratio (9.51) than 60.87% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that CDRE is somewhat dependend on debt financing.
The Debt to Equity ratio of CDRE (0.91) is worse than 72.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 9.51
Altman-Z 3.25
ROIC/WACC0.73
WACC9.75%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

CDRE has a Current Ratio of 3.59. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CDRE (3.59) is better than 78.26% of its industry peers.
CDRE has a Quick Ratio of 2.56. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.56, CDRE is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.59
Quick Ratio 2.56
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for CDRE have decreased by -8.74% in the last year.
CDRE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 34.28% yearly.
The Revenue has been growing slightly by 7.66% in the past year.
CDRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.17% yearly.
EPS 1Y (TTM)-8.74%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%-3.23%
Revenue 1Y (TTM)7.66%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%8.87%

3.2 Future

The Earnings Per Share is expected to grow by 19.48% on average over the next years. This is quite good.
Based on estimates for the next years, CDRE will show a quite strong growth in Revenue. The Revenue will grow by 8.99% on average per year.
EPS Next Y38.27%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
EPS Next 5YN/A
Revenue Next Year11.34%
Revenue Next 2Y9.51%
Revenue Next 3Y8.99%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 35.93, the valuation of CDRE can be described as expensive.
CDRE's Price/Earnings ratio is a bit cheaper when compared to the industry. CDRE is cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.38, CDRE is valued a bit more expensive.
The Price/Forward Earnings ratio is 23.59, which indicates a rather expensive current valuation of CDRE.
71.01% of the companies in the same industry are more expensive than CDRE, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CDRE to the average of the S&P500 Index (22.86), we can say CDRE is valued inline with the index average.
Industry RankSector Rank
PE 35.93
Fwd PE 23.59
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CDRE is valued a bit cheaper than 68.12% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CDRE is valued a bit cheaper than 71.01% of the companies in the same industry.
Industry RankSector Rank
P/FCF 41.06
EV/EBITDA 17.99
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CDRE may justify a higher PE ratio.
A more expensive valuation may be justified as CDRE's earnings are expected to grow with 19.48% in the coming years.
PEG (NY)0.94
PEG (5Y)N/A
EPS Next 2Y26.11%
EPS Next 3Y19.48%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.11%, CDRE has a reasonable but not impressive dividend return.
CDRE's Dividend Yield is rather good when compared to the industry average which is at 1.46. CDRE pays more dividend than 88.41% of the companies in the same industry.
With a Dividend Yield of 1.11, CDRE pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

CDRE has been paying a dividend for over 5 years, so it has already some track record.
CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

38.92% of the earnings are spent on dividend by CDRE. This is a low number and sustainable payout ratio.
DP38.92%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CADRE HOLDINGS INC

NYSE:CDRE (9/19/2025, 8:04:00 PM)

After market: 33.77 0 (0%)

33.77

-0.53 (-1.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners69.4%
Inst Owner Change-0.36%
Ins Owners30.6%
Ins Owner Change0%
Market Cap1.37B
Analysts78.46
Price Target39.27 (16.29%)
Short Float %6.84%
Short Ratio6.61
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP38.92%
Div Incr Years1
Div Non Decr Years3
Ex-Date08-01 2025-08-01 (0.095)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.6%
Min EPS beat(2)11.29%
Max EPS beat(2)87.91%
EPS beat(4)3
Avg EPS beat(4)27.62%
Min EPS beat(4)-31.8%
Max EPS beat(4)87.91%
EPS beat(8)6
Avg EPS beat(8)20.75%
EPS beat(12)8
Avg EPS beat(12)16%
EPS beat(16)10
Avg EPS beat(16)32.32%
Revenue beat(2)2
Avg Revenue beat(2)2.38%
Min Revenue beat(2)0.27%
Max Revenue beat(2)4.48%
Revenue beat(4)3
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-15.05%
Max Revenue beat(4)4.48%
Revenue beat(8)6
Avg Revenue beat(8)0.05%
Revenue beat(12)9
Avg Revenue beat(12)0.71%
Revenue beat(16)11
Avg Revenue beat(16)0.59%
PT rev (1m)-9.77%
PT rev (3m)-9.77%
EPS NQ rev (1m)-3.2%
EPS NQ rev (3m)-23.74%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.67%
Valuation
Industry RankSector Rank
PE 35.93
Fwd PE 23.59
P/S 2.4
P/FCF 41.06
P/OCF 35.69
P/B 4.13
P/tB 43.47
EV/EBITDA 17.99
EPS(TTM)0.94
EY2.78%
EPS(NY)1.43
Fwd EY4.24%
FCF(TTM)0.82
FCFY2.44%
OCF(TTM)0.95
OCFY2.8%
SpS14.08
BVpS8.18
TBVpS0.78
PEG (NY)0.94
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.8%
ROE 11.46%
ROCE 10.17%
ROIC 7.1%
ROICexc 8.87%
ROICexgc 19.55%
OM 12.22%
PM (TTM) 6.65%
GM 41.49%
FCFM 5.84%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
ROICexc(3y)11.24%
ROICexc(5y)14.1%
ROICexgc(3y)24.24%
ROICexgc(5y)30.41%
ROCE(3y)12.41%
ROCE(5y)17.14%
ROICexcg growth 3Y-11.18%
ROICexcg growth 5Y5.68%
ROICexc growth 3Y-14.82%
ROICexc growth 5Y2.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 9.51
Debt/EBITDA 3.49
Cap/Depr 30.73%
Cap/Sales 0.88%
Interest Coverage 4.33
Cash Conversion 44.54%
Profit Quality 87.78%
Current Ratio 3.59
Quick Ratio 2.56
Altman-Z 3.25
F-Score5
WACC9.75%
ROIC/WACC0.73
Cap/Depr(3y)35.32%
Cap/Depr(5y)31.71%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.04%
Profit Quality(3y)322.36%
Profit Quality(5y)273.24%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.74%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%-3.23%
EPS Next Y38.27%
EPS Next 2Y26.11%
EPS Next 3Y19.48%
EPS Next 5YN/A
Revenue 1Y (TTM)7.66%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%8.87%
Revenue Next Year11.34%
Revenue Next 2Y9.51%
Revenue Next 3Y8.99%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3Y9.65%
EBIT growth 5Y15.18%
EBIT Next Year76.73%
EBIT Next 3Y30.01%
EBIT Next 5YN/A
FCF growth 1Y-26.08%
FCF growth 3Y-11.18%
FCF growth 5Y43.24%
OCF growth 1Y-22.52%
OCF growth 3Y-7.45%
OCF growth 5Y33.8%